<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8044C2F3-70A8-44B3-A919-3A5ADEFD2311"><gtr:id>8044C2F3-70A8-44B3-A919-3A5ADEFD2311</gtr:id><gtr:name>Francis Crick Institute</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8044C2F3-70A8-44B3-A919-3A5ADEFD2311"><gtr:id>8044C2F3-70A8-44B3-A919-3A5ADEFD2311</gtr:id><gtr:name>Francis Crick Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E9A593F1-4BE5-4530-AEA2-5D202D2E907C"><gtr:id>E9A593F1-4BE5-4530-AEA2-5D202D2E907C</gtr:id><gtr:firstName>Dimitrios</gtr:firstName><gtr:surname>Anastasiou</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1202%2F1"><gtr:id>E0E62A79-6F19-44D1-8521-AF3BA69AFF28</gtr:id><gtr:title>Cancer metabolism</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1202/1</gtr:grantReference><gtr:abstractText>Cancer remains one of the leading causes of death worldwide, despite significant advances in our understanding of its biology. Development of cancer therapeutics is challenging due, partly, to the vast diversity of the disease and underlying causes. A key attribute of successful cancer therapies is their ability to selectively target tumors while sparing healthy tissues. Therefore, identifying features that are common to a broad spectrum of cancers and distinguish them from normal cells is an important objective in cancer research. One such distinguishing feature of cancer cells is the way they use nutrients to survive and multiply, i.e. their metabolism.
Our research aims at understanding how nutrient metabolism contributes to cancer development. Towards this goal, we are employing a multidisciplinary approach that includes metabolomics, biochemistry, microscopy, proteomics and mouse models, to elucidate the molecular mechanisms that distinguish the metabolism of tumors from that of normal tissues. A further aim of our work is to define principles for rational targeting of cancer metabolism as a therapeutic strategy.</gtr:abstractText><gtr:technicalSummary>Cancer cells utilise nutrients in a distinct manner compared to most normal cells. This phenomenon reflects, in part, an increased demand for cellular building blocks to support proliferation, as well as a need to deal with the unique challenges that cancer cells face from their environment. One aspect of our recent work has focused on the glycolytic enzyme PKM2. We showed that PKM2 helps cancer cells survive under oxidative stress elicited by low oxygen concentrations (hypoxia), a condition often encountered in tumours, by altering the way they metabolize glucose. Small molecule activators of PKM2 disrupt this process to impede proliferation and sensitize cancers to oxidant-induced death. Our results indicate that activation of PKM2 could be a useful therapeutic approach for a broad spectrum of cancers and suggest clinical settings where PKM2 activators could be effectively combined with existing drugs to improve their therapeutic potential.
Our lab currently continues to investigate the molecular mechanisms that underlie the characteristic metabolism of tumours using biochemical and metabolomics approaches. A major theme focuses on identifying alternative carbon sources (i.e. carbon sources other than glucose and glutamine, which are known to be heavily used by cancer cells) that fuel anabolic processes or are required for other aspects of cancer development. We are further interested in understanding how the metabolic features of individual cell types within the tumour niche influence cancer development. Towards this goal, we are developing advanced mouse cancer models that permit genetic manipulation of metabolic enzyme activities in individual cell types found within the tumour microenvironment. These studies are complemented by structure-based design of molecular biosensors to probe metabolism in vivo, at the single-cell level.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1182595</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Francis Crick Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Metabolic reprogramming in T cell development &amp;amp; function</gtr:description><gtr:id>5C308854-90EF-4800-BA29-0F74C64883BD</gtr:id><gtr:impact>Since the last reporting period, the sandwich strident assigned to this project has contributed to the elucidation of a mechanism that explains how glucose metabolism contributes to T cell function and this work is now under submission. This has been a multidisciplinary project that brings together the fields of cancer, biochemistry, metabolism and immunology and formed the basis of a long-standing and fruitful collaboration between our cancer lab with that of an immunologist.</gtr:impact><gtr:outcomeId>n4XK2sy68Jn-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise in the area of T cell development and function and carry out experimental work.</gtr:partnerContribution><gtr:piContribution>Provided expertise in the area of metabolism, data interpretation, metabolism-related hypothesis generation, technical input for the selected experimental approaches and regular mentorship for strategic development of the project.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Metabolic reprogramming in lung disease</gtr:description><gtr:id>6416F9AE-E1DD-4A3F-B778-5650D3F6D70A</gtr:id><gtr:impact>We have successfully applied for a competitive UCL BRC - Francis Crick Institute Clinical Research Training Fellowship. This is a multidisciplinary collaboration that brings together the fields of cancer, lung disease, metabolism and biochemistry within a clinical context.</gtr:impact><gtr:outcomeId>mmKPtXuaCt2-1</gtr:outcomeId><gtr:partnerContribution>Provided preliminary data, tools and technical expertise in lung disease phenotype analysis.</gtr:partnerContribution><gtr:piContribution>Provided expertise in the area of metabolic reprogramming and substantial input in the experimental approaches employed. Contributed to data interpretation and generation of new hypotheses. Provided expertise in the use of glycolytic enzyme modulators in animal studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Chemical biological tools to study cancer metabolism</gtr:description><gtr:id>A1C6240B-A66F-4B5D-9B79-3B0FAEED84BB</gtr:id><gtr:impact>An MRes student was successfully recruited and synthesised a series of compound analogues to modulate the activity of glycolytic enzymes. These compounds have been validated for activity with recombinant enzymes in our lab and are currently under further development in cell systems. This has been a multidisciplinary collaboration involving enzymology, biochemistry, microscopy and chemistry.</gtr:impact><gtr:outcomeId>qBSJHm6TjDJ-1</gtr:outcomeId><gtr:partnerContribution>They provided organic chemistry synthesis expertise</gtr:partnerContribution><gtr:piContribution>I conceived the project and provide technical expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Mitochondrial disease conference incl patient advocates.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6826A846-2E10-4330-934C-D972DD5E3B6D</gtr:id><gtr:impact>I gave a talk related to my lab's work on mitochondrial biology, to an audience comprising scientists researching mitochondria-related diseases and included patient advocates.</gtr:impact><gtr:outcomeId>58a47b726cef72.61074413</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.itn-meet.org/index.php?id0=final_events</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GSK open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5BCBC174-6A93-4A6A-A07A-90DFEDCADE5E</gtr:id><gtr:impact>The purpose was to disseminate information regarding ongoing academia-industry collaborations to strengthen the LinkLabs scheme between GSK and the Crick.</gtr:impact><gtr:outcomeId>58a47a659f7467.33189484</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRes studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Imperial College London</gtr:fundingOrg><gtr:id>157603A2-2B8A-4DF0-9D6A-DAF148BFB65B</gtr:id><gtr:outcomeId>545df7b30e4040.40673281</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>A Python script used to objectively assign thresholds for selecting screening hits candidates.</gtr:description><gtr:id>5694B462-635D-4331-9598-658AFB47FAC6</gtr:id><gtr:impact>Ability to objectively define a threshold for selection of hits in proteomic/metabolomic datasets that involve ratiometric outputs.</gtr:impact><gtr:outcomeId>545e0513567fb8.05914329</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Bayesian statistical analysis of proteomics datasets</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Chemical synthesis of substrate analogues to study the biology of monocarboxylate transporters.</gtr:description><gtr:id>475F70D3-A38B-4904-9483-240FE366A49A</gtr:id><gtr:impact>Novel insights into MCT biology. MCTs have been implicated in cancer but little is known about their function.</gtr:impact><gtr:outcomeId>58a48033f14e79.16085845</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Chemical to stay MCT biology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have implemented a series of models for liver regeneration and cancer in mice.</gtr:description><gtr:id>50EBCDDA-469B-4032-9F33-8FEB7DCB1CE1</gtr:id><gtr:impact>Parallel investigations of liver regeneration and cancer have been lacking. These tools provide a unique insight into the functional links between cancer and liver damage.</gtr:impact><gtr:outcomeId>58a4808ae2f8c6.44811036</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mouse models of liver regeneration and cancer</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>You have developed methods to study metabolism in a dynamic setting in live animals using Magnetic Resonance Spectroscopy (MRS).</gtr:description><gtr:id>446941C9-0545-484C-A1DD-36270FAFC415</gtr:id><gtr:impact>Significant reduction in animal numbers plus refinement of study parameters (e.g. standardisation of tumour size endpoints). Unprecedented topological information on how metabolism is segregated between tumour and adjacent healthy tissue.</gtr:impact><gtr:outcomeId>58a47fb8df90c0.97644170</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>MRS</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>- Computational and biochemical methods to engineer optogenetic control of metabolic enzymes.
- And LED panel technology for optogenetic experiments in cultured cells.</gtr:description><gtr:id>2633BEBB-707A-4068-B728-9152EBE54629</gtr:id><gtr:impact>This is currently a proprietary unpublished method that is under development. Following publication, we are planning to make it available to the research community. Further discussions with technically adept organisation for development of the panel are underway.</gtr:impact><gtr:outcomeId>545dfab01e16f7.42871430</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Optogenetic tools for metabolic control</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>A Python script that allows the researcher to perform statistical analysis of large-scale proteomic/metabolomic datasets involving radiometric measurements.</gtr:description><gtr:id>AB873A18-50A0-44FD-87D3-CD07A3979604</gtr:id><gtr:impact>This script allows us to perform statistical evaluation of large-scale datasets and assign significance to proteomic/metabolomic screen hits using objective criteria.</gtr:impact><gtr:outcomeId>545dfbb70e01d8.40487805</gtr:outcomeId><gtr:title>Bayesian statistical analysis algorithm for analysis of high-throughput radiometric datasets</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>67FA4AD5-65AA-42E2-A1AD-1A0FBA0780EE</gtr:id><gtr:title>Tumour microenvironment factors shaping the cancer metabolism landscape.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bea4f8d61758290583cd0a61cc53938c"><gtr:id>bea4f8d61758290583cd0a61cc53938c</gtr:id><gtr:otherNames>Anastasiou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>58a478764d7363.08579989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBB71DEB-82E6-4FFA-A21A-ABF14A6AD701</gtr:id><gtr:title>The Lipid Kinase PI5P4K? Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12661ba20691a416b4e072f2df7c0d38"><gtr:id>12661ba20691a416b4e072f2df7c0d38</gtr:id><gtr:otherNames>Sumita K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56d98e86ce50b5.63726609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598072C0-3976-4E78-A0AF-4092852231F3</gtr:id><gtr:title>p73 keeps metabolic control in the family.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa593d1fc46fee384d2fc17e061b3225"><gtr:id>aa593d1fc46fee384d2fc17e061b3225</gtr:id><gtr:otherNames>Fets L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_22893_23_23907193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FEEB772-CB5A-4175-8087-AD7B0B83BBEA</gtr:id><gtr:title>Hippo's Q for a big liver.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bea4f8d61758290583cd0a61cc53938c"><gtr:id>bea4f8d61758290583cd0a61cc53938c</gtr:id><gtr:otherNames>Anastasiou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>58a4784facf062.76192745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B7748D0-3CF8-4654-9017-44E1B557F57E</gtr:id><gtr:title>An engineered photoswitchable mammalian pyruvate kinase.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83f669b119003edf74e7abd8d8726b5e"><gtr:id>83f669b119003edf74e7abd8d8726b5e</gtr:id><gtr:otherNames>Gehrig S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>5a2fd84d57d2d3.16194828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85C0047C-45AC-4A56-AD20-801BD7534D3A</gtr:id><gtr:title>Allosteric regulation of metabolism in cancer: endogenous mechanisms and considerations for drug design.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a28eecc7f3f232f9229191743f3599"><gtr:id>f7a28eecc7f3f232f9229191743f3599</gtr:id><gtr:otherNames>Macpherson JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>5a9d10ea69f437.54782461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>642FD482-F24A-4D1A-9884-F08C75649190</gtr:id><gtr:title>Metformin: a case of divide and conquer.</gtr:title><gtr:parentPublicationTitle>Breast cancer research : BCR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bea4f8d61758290583cd0a61cc53938c"><gtr:id>bea4f8d61758290583cd0a61cc53938c</gtr:id><gtr:otherNames>Anastasiou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-5411</gtr:issn><gtr:outcomeId>pm_22893_23_23510106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3BF773A-00BA-4C3F-B74A-6C7156D1F60A</gtr:id><gtr:title>Degradation of activated K-Ras orthologue via K-Ras-specific lysine residues is required for cytokinesis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12661ba20691a416b4e072f2df7c0d38"><gtr:id>12661ba20691a416b4e072f2df7c0d38</gtr:id><gtr:otherNames>Sumita K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545df5872d3580.56209278</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1202/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>